PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Why older adults must go to the front of the vaccine line

Study shows speeding up roll-out, prioritizing 60-plus could save 65,000 US lives in three months

2021-01-21
(Press-News.org) Vaccinating older adults for COVID-19 first will save substantially more U.S. lives than prioritizing other age groups, and the slower the vaccine rollout and more widespread the virus, the more critical it is to bring them to the front of the line.

That's one key takeaway from a new University of Colorado Boulder paper, published today in the journal Science, which uses mathematical modeling to make projections about how different distribution strategies would play out in countries around the globe.

The research has already informed policy recommendations by the Centers for Disease Control and the World Health Organization to prioritize older adults after medical workers.

Now, as policymakers decide how and whether to carry out that advice, the paper--which includes an interactive tool--presents the numbers behind the tough decision.

"Common sense would suggest you want to protect the older, most vulnerable people in the population first. But common sense also suggests you want to first protect front-line essential workers (like grocery store clerks and teachers) who are at higher risk of exposure," said senior author Daniel Larremore, a computational biologist in the Department of Computer Science and CU Boulder's BioFrontiers Institute. "When common sense leads you in two different directions, math can help you decide."

For the study, Larremore and lead author Kate Bubar, a graduate student in the Department of Applied Mathematics, teamed up with colleagues at the Harvard T.H. Chan School of Public Health and the University of Chicago.

They drew on demographic information from different countries, as well as up-to-date data on how many people have already tested positive for COVID-19, how quickly the virus is spreading, how fast vaccines are rolling out and their estimated efficacy.

Then they modeled what would happen in five different scenarios in which a different group got vaccinated first: Children and teenagers; adults ages 20 to 49; adults 20 or older; or adults 60 or older (considering that about 30% of those eligible might decline). In the fifth scenario, anyone who wanted a vaccine got one while supplies lasted.

Results from the United States, Belgium, Brazil, China, India, Poland, South Africa, Spain and Zimbabwe are included in the paper, with more countries included in the online tool.

Different strategies worked better or worse, depending on local circumstances, but a few key findings jumped out.

In most scenarios, across countries, prioritizing adults 60+ saved the most lives.

"Age is the strongest predictor of vulnerability," said Larremore, noting that while pre-existing conditions like asthma boost risk of severe illness or death, age boosts vulnerability more. "You have an exponentially higher likelihood of dying from COVID-19 as you get older."

The authors also note that, while the vaccines being distributed now are believed to have about a 90 to 95% chance of protecting against severe disease, researchers don't yet know how well they block infection and transmission. If they don't block it well and asymptomatic spreaders abound, it again makes the most sense to vaccinate older adults. If nothing else, they'll be personally protected against grave disease.

Only in scenarios where the virus is under control and the vaccine is known to block infection and transmission well does it make sense to move younger adults to the front of the line. That is not the situation in the United States right now.

"For essential workers who might be frustrated that they are not first, we hope this study offers some clarity," said Bubar. "We realize it is a big sacrifice for them to make but our study shows it will save lives."

So will a faster rollout, they found.

For instance, all other things being equal, if the rollout speed was to be doubled from current rates under current transmission conditions, COVID-19 mortality could be reduced by about 23%, or 65,000 lives, over the next three months.

The paper also suggests that in some situations where COVID has already infected large swaths of the population and vaccine is in short supply, it might make sense to ask younger adults who have already tested positive to step to the back of the line.

"Our research suggests that prioritizing people who have not yet had COVID could allow hard-hit communities to stretch those first doses further and possibly get to some of the herd immunity effects sooner," said Larremore.

The authors stress that vaccines alone are not the only tactic for helping win the race against COVID.

"To allow the vaccine to get to folks before the virus does, we need to not only roll out the vaccine quickly and get it to the most vulnerable people. We have to also keep our foot on the virus brake with masks, distancing and smart policies," said Larremore.

INFORMATION:



ELSE PRESS RELEASES FROM THIS DATE:

The downward trend: Nature's decline risks our quality of life

The downward trend: Natures decline risks our quality of life
2021-01-21
It is no secret that over the last few decades, humans have changed nature at an ever-increasing rate. A growing collection of research covers the many ways this is impacting our quality of life, from air quality to nutrition and income. To better understand how which areas are most at risk, scientists have combed through volumes of literature to present global trends in the relationship between human wellbeing and environmental degradation. Their work, which included Fabrice DeClerck from the Alliance of Bioversity International and CIAT, was summarized in "Global trends in nature's contributions to people", which was recently published in Proceedings of the National Academy of Sciences. This systematic ...

Combining best of both worlds for cancer modeling

Combining best of both worlds for cancer modeling
2021-01-21
WASHINGTON, January 21, 2021 -- Despite cancer being a leading cause of death worldwide, treatment options for many types of cancers remain limited. This is partly due to the in vitro tools used to model cancers, which cannot adequately predict the behavior of a cancer or its sensitivity to drugs. Further, animal models, like mice, biologically differ from humans in ways that play a critical role in immunotherapy, and results from animal studies do not always translate well to human disease. These shortcomings point to a clear need for a better, patient-specific model to improve the understanding of cancer cells and their impacts. Researchers from the University of Wisconsin and the University ...

Medicated drops may help close macular holes, helping some patients avoid surgery

2021-01-21
Medicated drops may help close small macular holes over a two- to eight-week period, allowing some people to avoid surgery to fix the vision problem, a new study suggests. The findings, based on a retrospective multicenter case series published Dec. 15, 2020, in Ophthalmology Retina, could lead to a better understanding of which patients may benefit from the treatment, as well as the timeline of the treatment's effectiveness. "For certain patients, medicated drops may heal their macular hole by decreasing inflammation and increasing fluid absorption in the retina," said ophthalmologist and retinal surgeon Dimitra Skondra, MD, PhD, senior author of the study. Skondra is an associate professor of ophthalmology and visual ...

Personalizing cancer care with improved tumor models

Personalizing cancer care with improved tumor models
2021-01-21
WASHINGTON, January 21, 2021 -- Cancer is a major, worldwide challenge, and its impact is projected to escalate due to aging and growth of the population. Researchers recognize that new approaches to diagnose and treat deadly cancers, including identifying new drugs to treat cancer, will be essential to curbing the growing impact of the disease. While decades of investment in research have resulted in substantial improvements in surviving cancer, a key challenge remains in identifying new drugs that improve outcomes for cancer patients, particularly for cancers when tumors have spread throughout the body. In APL Bioengineering, by AIP Publishing, researchers suggest a major hurdle to identifying new drugs is the paucity of models -- organisms ...

Study finds bilateral agreements help developing economies spur foreign investment

2021-01-21
EUGENE, Ore. -- Jan. 21, 2021 -- Developing economies suffer from a paradox: they don't receive investment flows from developed economies because they lack stability and high-quality financial and lawmaking institutions, but they can't develop those institutions without foreign funds. A study co-authored by Brandon Julio, a professor in the Department of Finance at the University of Oregon's Lundquist College of Business, found that bilateral investment treaties, commonly known as BITs, can help developing economies overcome this paradox, but only as long as those ...

Study finds genetic clues to pneumonia risk and COVID-19 disparities

Study finds genetic clues to pneumonia risk and COVID-19 disparities
2021-01-21
Researchers at Vanderbilt University Medical Center and colleagues have identified genetic factors that increase the risk for developing pneumonia and its severe, life-threatening consequences. Their findings, published recently in the American Journal of Human Genetics, may aid efforts to identify patients with COVID-19 at greatest risk for pneumonia, and enable earlier interventions to prevent severe illness and death. Despite the increasing availability of COVID-19 vaccines, it will take months to inoculate enough people to bring the pandemic under control, experts predict. In the meantime, thousands of Americans are hospitalized and die from COVID-19 each ...

How to get more electric cars on the road

2021-01-21
A new study from researchers at MIT uncovers the kinds of infrastructure improvements that would make the biggest difference in increasing the number of electric cars on the road, a key step toward reducing greenhouse gas emissions from transportation. The researchers found that installing charging stations on residential streets, rather than just in central locations such as shopping malls, could have an outsized benefit. They also found that adding on high-speed charging stations along highways and making supplementary vehicles more easily available to people who need to travel beyond the single-charge range of their electric vehicles could greatly increase the vehicle electrification potential. The findings are reported today in the journal Nature Energy, in a paper by MIT associate ...

New study: nine out of ten US infants experience gut microbiome deficiency

New study: nine out of ten US infants experience gut microbiome deficiency
2021-01-21
DAVIS, Calif., January 21, 2020 - A new peer-reviewed study reveals that the vast majority of U.S. infants may be suffering from a substantial deficiency in an important bacterium key to breast milk utilization and immune system development, as well as protection against gut pathogens linked to common newborn conditions such as colic and diaper rash. According to the study published today in END ...

Snake sex chromosomes say less about sex and more about survival

Snake sex chromosomes say less about sex and more about survival
2021-01-21
Sex-specific chromosomes are a dangerous place to be, if you're a gene. Because these chromosomes -- Y chromosomes, in humans -- do not have a matching chromosome with which to exchange genetic information, they are prone to losing non-essential genes left and right in a process called genetic decay. Now, a new study from research scientist Daniel Winston Bellott in the lab of Whitehead Institute Member David Page broadens our understanding of what makes a gene able to survive on a sex-specific chromosome by looking at one especially slithery branch of the evolutionary tree: snakes. Comparing surviving genes on snake ...

Scientists make pivotal discovery on mechanism of Epstein-Barr virus latent infection

Scientists make pivotal discovery on mechanism of Epstein-Barr virus latent infection
2021-01-21
PHILADELPHIA -- (Jan. 21, 2021) -- Researchers at The Wistar Institute have discovered a new enzymatic function of the Epstein-Barr Virus (EBV) protein EBNA1, a critical factor in EBV's ability to transform human cells and cause cancer. Published in Cell, this study provides new indications for inhibiting EBNA1 function, opening up fresh avenues for development of therapies to treat EBV-associated cancers. EBV establishes life-long, latent infection in B lymphocytes, which can contribute to development of different cancer types, including Burkitt's lymphoma, nasopharyngeal carcinoma (NPC) and Hodgkin's lymphoma. The Epstein-Barr Nuclear Antigen 1 (EBNA1) serves as an attractive therapeutic ...

LAST 30 PRESS RELEASES:

Fig trees convert atmospheric CO2 to stone

Intra-arterial tenecteplase for acute stroke after successful endovascular therapy

Study reveals beneficial microbes that can sustain yields in unfertilized fields

Robotic probe quickly measures key properties of new materials

Climate change cuts milk production, even when farmers cool their cows

Frozen, but not sealed: Arctic Ocean remained open to life during ice ages

Some like it cold: Cryorhodopsins

Demystifying gut bacteria with AI

Human wellbeing on a finite planet towards 2100: new study shows humanity at a crossroads

Unlocking the hidden biodiversity of Europe’s villages

Planned hydrogen refuelling stations may lead to millions of euros in yearly losses

Planned C-sections increase the risk of certain childhood cancers

Adults who have survived childhood cancer are at increased risk of severe COVID-19

Drones reveal extreme coral mortality after bleaching

New genetic finding uncovers hidden cause of arsenic resistance in acute promyelocytic leukemia

Native habitats hold the key to the much-loved smashed avocado’s future

Using lightning to make ammonia out of thin air

Machine learning potential-driven insights into pH-dependent CO₂ reduction

Physician associates provide safe care for diagnosed patients when directly supervised by a doctor

How game-play with robots can bring out their human side

Asthma: patient expectations influence the course of the disease

UNM physician tests drug that causes nerve tissue to emit light, enabling faster, safer surgery

New study identifies EMP1 as a key driver of pancreatic cancer progression and poor prognosis

XPR1 identified as a key regulator of ovarian cancer growth through autophagy and immune evasion

Flexible, eco-friendly electronic plastic for wearable tech, sensors

Can the Large Hadron Collider snap string theory?

Stuckeman professor’s new book explores ‘socially sustainable’ architecture

Synthetic DNA nanoparticles for gene therapy

New model to find treatments for an aggressive blood cancer

Special issue of Journal of Intensive Medicine analyzes non-invasive respiratory support

[Press-News.org] Why older adults must go to the front of the vaccine line
Study shows speeding up roll-out, prioritizing 60-plus could save 65,000 US lives in three months